Sam Brusco, Associate Editor09.07.23
Silony Medical, a self-proclaimed growing challenger to “big medtech” for the global spinal fusion market, began an agreement to acquire Centinel Spine’s Global Fusion business. Financial terms were not disclosed.
The transaction combines Solony’s Verticale posterior screw and rod fusion system as well as its Roccia and Favo interbody fusion systems with Centinel’s STALIF tech platform. Silony said this will create a first-in-class occiput to sacrum, posterior, later, and anterior spinal fusion portfolio for both open and minimally invasive surgeries.
"Adding Centinel's Fusion Products to Silony's portfolio significantly strengthens our technological and geographic footprint, without cannibalizing products and sales regions," Silony CEO Constantin Schoen told the press. "Uniting stand-alone/screw integrated cervical and lumbar solutions with our predominantly posterior capabilities is a logical move, that will further accelerate our global growth."
Silony also gains a team of Centinel professionals with expertise in the anterior fusion market. The company restated its commitment to successful, long-term relationships and expressed looking forward to working with the established global STALIF distributor, surgeon, and hospital partners.
The transaction is expected to close within 45 days.
The transaction combines Solony’s Verticale posterior screw and rod fusion system as well as its Roccia and Favo interbody fusion systems with Centinel’s STALIF tech platform. Silony said this will create a first-in-class occiput to sacrum, posterior, later, and anterior spinal fusion portfolio for both open and minimally invasive surgeries.
"Adding Centinel's Fusion Products to Silony's portfolio significantly strengthens our technological and geographic footprint, without cannibalizing products and sales regions," Silony CEO Constantin Schoen told the press. "Uniting stand-alone/screw integrated cervical and lumbar solutions with our predominantly posterior capabilities is a logical move, that will further accelerate our global growth."
Silony also gains a team of Centinel professionals with expertise in the anterior fusion market. The company restated its commitment to successful, long-term relationships and expressed looking forward to working with the established global STALIF distributor, surgeon, and hospital partners.
The transaction is expected to close within 45 days.